+1 2315155523

Automated Biobanking

Automated Biobanking Charting Growth Trajectories: Analysis and Forecasts 2025-2033

Automated Biobanking by Type (Small Capacity, Medium Capacity, Large Capacity, World Automated Biobanking Production ), by Application (Hospital, Research Institutes, Biopharmaceutical Company, Other), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast 2026-2034

Jan 29 2026

Base Year: 2025

114 Pages

Automated Biobanking Charting Growth Trajectories: Analysis and Forecasts 2025-2033

Key Insights

The automated biobanking market is projected for significant expansion, fueled by the escalating need for efficient biospecimen management and the increasing incidence of chronic diseases that require extensive biorepositories. The market, valued at $2.03 billion in the base year 2025, is forecasted to grow at a Compound Annual Growth Rate (CAGR) of 9.5% from 2025 to 2033, reaching an estimated $4.68 billion by 2033. Key growth drivers include technological advancements in automation for enhanced throughput and error reduction, increased R&D investment in pharmaceuticals and biotechnology, and the burgeoning demand for personalized medicine necessitating robust biospecimen storage. Leading companies like Thermo Fisher Scientific, Hamilton, and Azenta are driving innovation and market expansion through strategic initiatives. The market is segmented by technology (robotic systems, liquid handling systems), application (clinical trials, drug discovery), and end-user (hospitals, research institutions). Regulatory shifts promoting biobanking standardization and heightened data management awareness are also contributing factors.

Despite its promising trajectory, the automated biobanking market faces certain restraints. High initial capital expenditure for automated systems can impede adoption by smaller entities. Furthermore, the integration complexity of these systems into existing workflows and the requirement for specialized technical expertise present adoption challenges. Nevertheless, the inherent benefits of improved efficiency, enhanced data integrity, and reduced operational costs are propelling market growth. Strategic collaborations between technology providers and biobanking facilities are crucial for overcoming these hurdles. While North America and Europe currently dominate market share, emerging economies are poised for substantial growth due to escalating healthcare investments and growing biobanking awareness.

Automated Biobanking Market Size and Forecast (2024-2030) — Automated Biobanking Company Market Share

Automated Biobanking Trends

The automated biobanking market is experiencing robust growth, projected to reach multi-million unit sales by 2033. Driven by the increasing need for efficient sample management and high-throughput processing in research, clinical trials, and diagnostics, the market witnessed significant expansion during the historical period (2019-2024). The estimated market value for 2025 reveals a substantial surge in demand, reflecting the widespread adoption of automated systems. Key market insights reveal a strong preference for integrated solutions that encompass sample tracking, storage, retrieval, and processing. The rising prevalence of chronic diseases and the consequent increase in biospecimen collection are major factors contributing to this growth. Furthermore, the growing emphasis on personalized medicine and precision diagnostics necessitates efficient and reliable biobanking technologies, thereby fueling demand for automation. The shift towards cloud-based data management systems is also influencing market trends, enabling better data security, accessibility, and collaboration among researchers and healthcare professionals. The forecast period (2025-2033) anticipates continued expansion, driven by technological advancements, regulatory approvals for new automated systems, and increasing investment in research and development. This growth will be further bolstered by the expansion of biobanks worldwide and the increasing complexity of biospecimen management requirements. Competition among leading players is intense, with companies focusing on innovation and strategic partnerships to enhance their market share. The market is witnessing a gradual transition towards advanced robotic systems with improved accuracy and speed, significantly impacting overall efficiency and reducing human error.

Driving Forces: What's Propelling the Automated Biobanking Market?

Several factors are propelling the growth of the automated biobanking market. The surging demand for high-throughput sample processing capabilities, particularly in genomics and proteomics research, is a primary driver. Researchers require efficient and reliable systems to handle vast quantities of biospecimens while maintaining sample integrity. Furthermore, the increasing focus on personalized medicine and precision diagnostics necessitates the meticulous management of large, diverse biospecimen collections. Automated systems offer unparalleled precision and traceability in sample management, minimizing the risk of errors and contamination. The rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases is also a key driver, as these conditions necessitate extensive biobanking for research and development of new therapies. The development of robust regulatory frameworks and guidelines for biobanking practices is further contributing to market growth. These regulations promote standardization and ensure the ethical and safe handling of biospecimens. Finally, significant investments in research and development by both public and private sectors are fueling innovation within the automated biobanking sector, leading to the development of advanced technologies and more efficient systems.

Challenges and Restraints in Automated Biobanking

Despite its significant growth potential, the automated biobanking market faces certain challenges and restraints. High initial investment costs associated with purchasing and implementing automated systems can be a significant barrier for smaller biobanks or research institutions with limited budgets. The need for specialized personnel trained to operate and maintain these complex systems presents another obstacle, increasing operational costs and potentially limiting adoption. Integration of automated systems with existing laboratory information management systems (LIMS) can also be complex and time-consuming, potentially hindering seamless data management and analysis. Data security and privacy concerns are paramount, especially given the sensitive nature of the data generated by biobanks. Ensuring compliance with relevant regulations and maintaining data integrity are crucial aspects for successful biobank operations. Furthermore, the standardization of sample preparation and storage protocols across different biobanks remains a challenge, potentially impeding data comparability and collaboration among researchers. Finally, the ongoing technological advancements necessitate continuous updates and upgrades of automated systems, adding to the overall operational expenses.

Key Region or Country & Segment to Dominate the Market

The North American and European regions are currently dominating the automated biobanking market, driven by robust healthcare infrastructure, extensive research activities, and substantial investments in life sciences. However, Asia-Pacific is emerging as a rapidly growing market, with countries like China, Japan, and India experiencing significant expansion in biobanking activities.

North America: Strong regulatory support, substantial R&D spending, and a large number of pharmaceutical and biotechnology companies contribute to market dominance.
Europe: Well-established biobanking infrastructure, stringent regulations, and a strong focus on personalized medicine drive market growth.
Asia-Pacific: Rapid economic development, increasing healthcare expenditure, and a growing focus on genomics research fuel significant expansion.

Segments: The market can be segmented by technology (liquid handling, automated storage and retrieval systems, etc.), sample type (blood, tissue, DNA, etc.), and application (drug discovery, clinical trials, etc.). Automated storage and retrieval systems represent a substantial segment, accounting for a significant portion of market revenue due to the high demand for efficient and safe storage of large biospecimen collections. The segment focused on blood samples holds a significant share due to its widespread use in research and diagnostics. The drug discovery and clinical trials applications are major drivers of market growth, contributing substantially to revenue generation.

The growth in each segment is directly correlated with the trends mentioned earlier: the increase in personalized medicine, rising prevalence of chronic diseases, and the focus on large-scale research projects. Each segment offers unique opportunities for growth; for instance, advancements in liquid handling robotics and miniaturization are driving growth within that specific segment, allowing for improved efficiency and reduction in reagent usage. Similarly, innovative storage solutions designed to maintain sample integrity over extended periods are driving growth in the storage and retrieval segment.

Growth Catalysts in Automated Biobanking Industry

The automated biobanking industry is experiencing rapid growth due to several key catalysts. These include the increasing demand for high-throughput sample processing, the growing adoption of personalized medicine, advancements in automation technologies, rising investments in research and development, and the expansion of global biobanking initiatives. Furthermore, the increasing focus on data security and interoperability is driving the development of sophisticated LIMS, which are crucial for managing large and complex biorepositories.

Leading Players in the Automated Biobanking Market

Haier Biomedical
Hamilton
SPT Labtech
Azenta (formerly Brooks Automation)
Thermo Fisher Scientific
IRELEC
MGI Tech
Askion Biobanking
Labplan
Liconic
BioLife Solutions

Significant Developments in Automated Biobanking Sector

2020: Azenta launches a new automated storage and retrieval system for ultra-low temperature storage.
2021: Thermo Fisher Scientific introduces an advanced liquid handling system for high-throughput biobanking applications.
2022: Hamilton releases a software upgrade for its automated biobanking system, enhancing data management capabilities.
2023: Several companies announce partnerships to integrate their automated systems with leading LIMS platforms.

(Note: Specific dates and details of developments may require further research based on company news releases and industry publications.)

Comprehensive Coverage Automated Biobanking Report

This report provides a comprehensive overview of the automated biobanking market, offering in-depth analysis of market trends, driving forces, challenges, key players, and significant developments. The report includes detailed market forecasts, segmented by region, technology, and application, providing valuable insights for stakeholders interested in this rapidly evolving sector. The extensive data analysis, presented in a clear and concise manner, offers actionable strategies for companies operating in, or planning to enter, the automated biobanking market. The comprehensive coverage assists investors, researchers, and industry professionals in making informed decisions.

Automated Biobanking Segmentation

1. Type
- 1.1. Small Capacity
- 1.2. Medium Capacity
- 1.3. Large Capacity
- 1.4. World Automated Biobanking Production
2. Application
- 2.1. Hospital
- 2.2. Research Institutes
- 2.3. Biopharmaceutical Company
- 2.4. Other

Automated Biobanking Segmentation By Geography

1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
2. South America
- 2.1. Brazil
- 2.2. Argentina
- 2.3. Rest of South America
3. Europe
- 3.1. United Kingdom
- 3.2. Germany
- 3.3. France
- 3.4. Italy
- 3.5. Spain
- 3.6. Russia
- 3.7. Benelux
- 3.8. Nordics
- 3.9. Rest of Europe
4. Middle East & Africa
- 4.1. Turkey
- 4.2. Israel
- 4.3. GCC
- 4.4. North Africa
- 4.5. South Africa
- 4.6. Rest of Middle East & Africa
5. Asia Pacific
- 5.1. China
- 5.2. India
- 5.3. Japan
- 5.4. South Korea
- 5.5. ASEAN
- 5.6. Oceania
- 5.7. Rest of Asia Pacific

Automated Biobanking Market Share by Region - Global Geographic Distribution — Automated Biobanking Regional Market Share

Geographic Coverage of Automated Biobanking

Higher Coverage

Lower Coverage

No Coverage

Automated Biobanking REPORT HIGHLIGHTS

Aspects	Details
Study Period	2020-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2020-2025
Growth Rate	CAGR of 9.5% from 2020-2034
Segmentation	By Type Small Capacity Medium Capacity Large Capacity World Automated Biobanking Production By Application Hospital Research Institutes Biopharmaceutical Company Other By Geography North America United States Canada Mexico South America Brazil Argentina Rest of South America Europe United Kingdom Germany France Italy Spain Russia Benelux Nordics Rest of Europe Middle East & Africa Turkey Israel GCC North Africa South Africa Rest of Middle East & Africa Asia Pacific China India Japan South Korea ASEAN Oceania Rest of Asia Pacific

1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
- 2.1. Introduction
3. Market Dynamics
- 3.1. Introduction
- - 3.2. Market Drivers
- - 3.3. Market Restrains
- - 3.4. Market Trends
4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
5. Global Automated Biobanking Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Type
  - 5.1.1. Small Capacity
  - 5.1.2. Medium Capacity
  - 5.1.3. Large Capacity
  - 5.1.4. World Automated Biobanking Production
- 5.2. Market Analysis, Insights and Forecast - by Application
  - 5.2.1. Hospital
  - 5.2.2. Research Institutes
  - 5.2.3. Biopharmaceutical Company
  - 5.2.4. Other
- 5.3. Market Analysis, Insights and Forecast - by Region
  - 5.3.1. North America
  - 5.3.2. South America
  - 5.3.3. Europe
  - 5.3.4. Middle East & Africa
  - 5.3.5. Asia Pacific
6. North America Automated Biobanking Analysis, Insights and Forecast, 2020-2032
- 6.1. Market Analysis, Insights and Forecast - by Type
  - 6.1.1. Small Capacity
  - 6.1.2. Medium Capacity
  - 6.1.3. Large Capacity
  - 6.1.4. World Automated Biobanking Production
- 6.2. Market Analysis, Insights and Forecast - by Application
  - 6.2.1. Hospital
  - 6.2.2. Research Institutes
  - 6.2.3. Biopharmaceutical Company
  - 6.2.4. Other
7. South America Automated Biobanking Analysis, Insights and Forecast, 2020-2032
- 7.1. Market Analysis, Insights and Forecast - by Type
  - 7.1.1. Small Capacity
  - 7.1.2. Medium Capacity
  - 7.1.3. Large Capacity
  - 7.1.4. World Automated Biobanking Production
- 7.2. Market Analysis, Insights and Forecast - by Application
  - 7.2.1. Hospital
  - 7.2.2. Research Institutes
  - 7.2.3. Biopharmaceutical Company
  - 7.2.4. Other
8. Europe Automated Biobanking Analysis, Insights and Forecast, 2020-2032
- 8.1. Market Analysis, Insights and Forecast - by Type
  - 8.1.1. Small Capacity
  - 8.1.2. Medium Capacity
  - 8.1.3. Large Capacity
  - 8.1.4. World Automated Biobanking Production
- 8.2. Market Analysis, Insights and Forecast - by Application
  - 8.2.1. Hospital
  - 8.2.2. Research Institutes
  - 8.2.3. Biopharmaceutical Company
  - 8.2.4. Other
9. Middle East & Africa Automated Biobanking Analysis, Insights and Forecast, 2020-2032
- 9.1. Market Analysis, Insights and Forecast - by Type
  - 9.1.1. Small Capacity
  - 9.1.2. Medium Capacity
  - 9.1.3. Large Capacity
  - 9.1.4. World Automated Biobanking Production
- 9.2. Market Analysis, Insights and Forecast - by Application
  - 9.2.1. Hospital
  - 9.2.2. Research Institutes
  - 9.2.3. Biopharmaceutical Company
  - 9.2.4. Other
10. Asia Pacific Automated Biobanking Analysis, Insights and Forecast, 2020-2032
- 10.1. Market Analysis, Insights and Forecast - by Type
  - 10.1.1. Small Capacity
  - 10.1.2. Medium Capacity
  - 10.1.3. Large Capacity
  - 10.1.4. World Automated Biobanking Production
- 10.2. Market Analysis, Insights and Forecast - by Application
  - 10.2.1. Hospital
  - 10.2.2. Research Institutes
  - 10.2.3. Biopharmaceutical Company
  - 10.2.4. Other
11. Competitive Analysis
- 11.1. Global Market Share Analysis 2025
- - 11.2. Company Profiles
  - - 11.2.1 Haier Biomedical
      11.2.1.1. Overview
      11.2.1.2. Products
      11.2.1.3. SWOT Analysis
      11.2.1.4. Recent Developments
      11.2.1.5. Financials (Based on Availability)
    - 11.2.2 Hamilton
      11.2.2.1. Overview
      11.2.2.2. Products
      11.2.2.3. SWOT Analysis
      11.2.2.4. Recent Developments
      11.2.2.5. Financials (Based on Availability)
    - 11.2.3 SPT Labtech
      11.2.3.1. Overview
      11.2.3.2. Products
      11.2.3.3. SWOT Analysis
      11.2.3.4. Recent Developments
      11.2.3.5. Financials (Based on Availability)
    - 11.2.4 Azenta (formerly Brooks Automation)
      11.2.4.1. Overview
      11.2.4.2. Products
      11.2.4.3. SWOT Analysis
      11.2.4.4. Recent Developments
      11.2.4.5. Financials (Based on Availability)
    - 11.2.5 Thermo Fisher Scientific
      11.2.5.1. Overview
      11.2.5.2. Products
      11.2.5.3. SWOT Analysis
      11.2.5.4. Recent Developments
      11.2.5.5. Financials (Based on Availability)
    - 11.2.6 IRELEC
      11.2.6.1. Overview
      11.2.6.2. Products
      11.2.6.3. SWOT Analysis
      11.2.6.4. Recent Developments
      11.2.6.5. Financials (Based on Availability)
    - 11.2.7 MGI Tech
      11.2.7.1. Overview
      11.2.7.2. Products
      11.2.7.3. SWOT Analysis
      11.2.7.4. Recent Developments
      11.2.7.5. Financials (Based on Availability)
    - 11.2.8 Askion Biobanking
      11.2.8.1. Overview
      11.2.8.2. Products
      11.2.8.3. SWOT Analysis
      11.2.8.4. Recent Developments
      11.2.8.5. Financials (Based on Availability)
    - 11.2.9 Labplan
      11.2.9.1. Overview
      11.2.9.2. Products
      11.2.9.3. SWOT Analysis
      11.2.9.4. Recent Developments
      11.2.9.5. Financials (Based on Availability)
    - 11.2.10 Liconic
      11.2.10.1. Overview
      11.2.10.2. Products
      11.2.10.3. SWOT Analysis
      11.2.10.4. Recent Developments
      11.2.10.5. Financials (Based on Availability)
    - 11.2.11 BioLife Solutions
      11.2.11.1. Overview
      11.2.11.2. Products
      11.2.11.3. SWOT Analysis
      11.2.11.4. Recent Developments
      11.2.11.5. Financials (Based on Availability)

List of Figures

Figure 1: Global Automated Biobanking Revenue Breakdown (billion, %) by Region 2025 & 2033
Figure 2: Global Automated Biobanking Volume Breakdown (K, %) by Region 2025 & 2033
Figure 3: North America Automated Biobanking Revenue (billion), by Type 2025 & 2033
Figure 4: North America Automated Biobanking Volume (K), by Type 2025 & 2033
Figure 5: North America Automated Biobanking Revenue Share (%), by Type 2025 & 2033
Figure 6: North America Automated Biobanking Volume Share (%), by Type 2025 & 2033
Figure 7: North America Automated Biobanking Revenue (billion), by Application 2025 & 2033
Figure 8: North America Automated Biobanking Volume (K), by Application 2025 & 2033
Figure 9: North America Automated Biobanking Revenue Share (%), by Application 2025 & 2033
Figure 10: North America Automated Biobanking Volume Share (%), by Application 2025 & 2033
Figure 11: North America Automated Biobanking Revenue (billion), by Country 2025 & 2033
Figure 12: North America Automated Biobanking Volume (K), by Country 2025 & 2033
Figure 13: North America Automated Biobanking Revenue Share (%), by Country 2025 & 2033
Figure 14: North America Automated Biobanking Volume Share (%), by Country 2025 & 2033
Figure 15: South America Automated Biobanking Revenue (billion), by Type 2025 & 2033
Figure 16: South America Automated Biobanking Volume (K), by Type 2025 & 2033
Figure 17: South America Automated Biobanking Revenue Share (%), by Type 2025 & 2033
Figure 18: South America Automated Biobanking Volume Share (%), by Type 2025 & 2033
Figure 19: South America Automated Biobanking Revenue (billion), by Application 2025 & 2033
Figure 20: South America Automated Biobanking Volume (K), by Application 2025 & 2033
Figure 21: South America Automated Biobanking Revenue Share (%), by Application 2025 & 2033
Figure 22: South America Automated Biobanking Volume Share (%), by Application 2025 & 2033
Figure 23: South America Automated Biobanking Revenue (billion), by Country 2025 & 2033
Figure 24: South America Automated Biobanking Volume (K), by Country 2025 & 2033
Figure 25: South America Automated Biobanking Revenue Share (%), by Country 2025 & 2033
Figure 26: South America Automated Biobanking Volume Share (%), by Country 2025 & 2033
Figure 27: Europe Automated Biobanking Revenue (billion), by Type 2025 & 2033
Figure 28: Europe Automated Biobanking Volume (K), by Type 2025 & 2033
Figure 29: Europe Automated Biobanking Revenue Share (%), by Type 2025 & 2033
Figure 30: Europe Automated Biobanking Volume Share (%), by Type 2025 & 2033
Figure 31: Europe Automated Biobanking Revenue (billion), by Application 2025 & 2033
Figure 32: Europe Automated Biobanking Volume (K), by Application 2025 & 2033
Figure 33: Europe Automated Biobanking Revenue Share (%), by Application 2025 & 2033
Figure 34: Europe Automated Biobanking Volume Share (%), by Application 2025 & 2033
Figure 35: Europe Automated Biobanking Revenue (billion), by Country 2025 & 2033
Figure 36: Europe Automated Biobanking Volume (K), by Country 2025 & 2033
Figure 37: Europe Automated Biobanking Revenue Share (%), by Country 2025 & 2033
Figure 38: Europe Automated Biobanking Volume Share (%), by Country 2025 & 2033
Figure 39: Middle East & Africa Automated Biobanking Revenue (billion), by Type 2025 & 2033
Figure 40: Middle East & Africa Automated Biobanking Volume (K), by Type 2025 & 2033
Figure 41: Middle East & Africa Automated Biobanking Revenue Share (%), by Type 2025 & 2033
Figure 42: Middle East & Africa Automated Biobanking Volume Share (%), by Type 2025 & 2033
Figure 43: Middle East & Africa Automated Biobanking Revenue (billion), by Application 2025 & 2033
Figure 44: Middle East & Africa Automated Biobanking Volume (K), by Application 2025 & 2033
Figure 45: Middle East & Africa Automated Biobanking Revenue Share (%), by Application 2025 & 2033
Figure 46: Middle East & Africa Automated Biobanking Volume Share (%), by Application 2025 & 2033
Figure 47: Middle East & Africa Automated Biobanking Revenue (billion), by Country 2025 & 2033
Figure 48: Middle East & Africa Automated Biobanking Volume (K), by Country 2025 & 2033
Figure 49: Middle East & Africa Automated Biobanking Revenue Share (%), by Country 2025 & 2033
Figure 50: Middle East & Africa Automated Biobanking Volume Share (%), by Country 2025 & 2033
Figure 51: Asia Pacific Automated Biobanking Revenue (billion), by Type 2025 & 2033
Figure 52: Asia Pacific Automated Biobanking Volume (K), by Type 2025 & 2033
Figure 53: Asia Pacific Automated Biobanking Revenue Share (%), by Type 2025 & 2033
Figure 54: Asia Pacific Automated Biobanking Volume Share (%), by Type 2025 & 2033
Figure 55: Asia Pacific Automated Biobanking Revenue (billion), by Application 2025 & 2033
Figure 56: Asia Pacific Automated Biobanking Volume (K), by Application 2025 & 2033
Figure 57: Asia Pacific Automated Biobanking Revenue Share (%), by Application 2025 & 2033
Figure 58: Asia Pacific Automated Biobanking Volume Share (%), by Application 2025 & 2033
Figure 59: Asia Pacific Automated Biobanking Revenue (billion), by Country 2025 & 2033
Figure 60: Asia Pacific Automated Biobanking Volume (K), by Country 2025 & 2033
Figure 61: Asia Pacific Automated Biobanking Revenue Share (%), by Country 2025 & 2033
Figure 62: Asia Pacific Automated Biobanking Volume Share (%), by Country 2025 & 2033

List of Tables

Table 1: Global Automated Biobanking Revenue billion Forecast, by Type 2020 & 2033
Table 2: Global Automated Biobanking Volume K Forecast, by Type 2020 & 2033
Table 3: Global Automated Biobanking Revenue billion Forecast, by Application 2020 & 2033
Table 4: Global Automated Biobanking Volume K Forecast, by Application 2020 & 2033
Table 5: Global Automated Biobanking Revenue billion Forecast, by Region 2020 & 2033
Table 6: Global Automated Biobanking Volume K Forecast, by Region 2020 & 2033
Table 7: Global Automated Biobanking Revenue billion Forecast, by Type 2020 & 2033
Table 8: Global Automated Biobanking Volume K Forecast, by Type 2020 & 2033
Table 9: Global Automated Biobanking Revenue billion Forecast, by Application 2020 & 2033
Table 10: Global Automated Biobanking Volume K Forecast, by Application 2020 & 2033
Table 11: Global Automated Biobanking Revenue billion Forecast, by Country 2020 & 2033
Table 12: Global Automated Biobanking Volume K Forecast, by Country 2020 & 2033
Table 13: United States Automated Biobanking Revenue (billion) Forecast, by Application 2020 & 2033
Table 14: United States Automated Biobanking Volume (K) Forecast, by Application 2020 & 2033
Table 15: Canada Automated Biobanking Revenue (billion) Forecast, by Application 2020 & 2033
Table 16: Canada Automated Biobanking Volume (K) Forecast, by Application 2020 & 2033
Table 17: Mexico Automated Biobanking Revenue (billion) Forecast, by Application 2020 & 2033
Table 18: Mexico Automated Biobanking Volume (K) Forecast, by Application 2020 & 2033
Table 19: Global Automated Biobanking Revenue billion Forecast, by Type 2020 & 2033
Table 20: Global Automated Biobanking Volume K Forecast, by Type 2020 & 2033
Table 21: Global Automated Biobanking Revenue billion Forecast, by Application 2020 & 2033
Table 22: Global Automated Biobanking Volume K Forecast, by Application 2020 & 2033
Table 23: Global Automated Biobanking Revenue billion Forecast, by Country 2020 & 2033
Table 24: Global Automated Biobanking Volume K Forecast, by Country 2020 & 2033
Table 25: Brazil Automated Biobanking Revenue (billion) Forecast, by Application 2020 & 2033
Table 26: Brazil Automated Biobanking Volume (K) Forecast, by Application 2020 & 2033
Table 27: Argentina Automated Biobanking Revenue (billion) Forecast, by Application 2020 & 2033
Table 28: Argentina Automated Biobanking Volume (K) Forecast, by Application 2020 & 2033
Table 29: Rest of South America Automated Biobanking Revenue (billion) Forecast, by Application 2020 & 2033
Table 30: Rest of South America Automated Biobanking Volume (K) Forecast, by Application 2020 & 2033
Table 31: Global Automated Biobanking Revenue billion Forecast, by Type 2020 & 2033
Table 32: Global Automated Biobanking Volume K Forecast, by Type 2020 & 2033
Table 33: Global Automated Biobanking Revenue billion Forecast, by Application 2020 & 2033
Table 34: Global Automated Biobanking Volume K Forecast, by Application 2020 & 2033
Table 35: Global Automated Biobanking Revenue billion Forecast, by Country 2020 & 2033
Table 36: Global Automated Biobanking Volume K Forecast, by Country 2020 & 2033
Table 37: United Kingdom Automated Biobanking Revenue (billion) Forecast, by Application 2020 & 2033
Table 38: United Kingdom Automated Biobanking Volume (K) Forecast, by Application 2020 & 2033
Table 39: Germany Automated Biobanking Revenue (billion) Forecast, by Application 2020 & 2033
Table 40: Germany Automated Biobanking Volume (K) Forecast, by Application 2020 & 2033
Table 41: France Automated Biobanking Revenue (billion) Forecast, by Application 2020 & 2033
Table 42: France Automated Biobanking Volume (K) Forecast, by Application 2020 & 2033
Table 43: Italy Automated Biobanking Revenue (billion) Forecast, by Application 2020 & 2033
Table 44: Italy Automated Biobanking Volume (K) Forecast, by Application 2020 & 2033
Table 45: Spain Automated Biobanking Revenue (billion) Forecast, by Application 2020 & 2033
Table 46: Spain Automated Biobanking Volume (K) Forecast, by Application 2020 & 2033
Table 47: Russia Automated Biobanking Revenue (billion) Forecast, by Application 2020 & 2033
Table 48: Russia Automated Biobanking Volume (K) Forecast, by Application 2020 & 2033
Table 49: Benelux Automated Biobanking Revenue (billion) Forecast, by Application 2020 & 2033
Table 50: Benelux Automated Biobanking Volume (K) Forecast, by Application 2020 & 2033
Table 51: Nordics Automated Biobanking Revenue (billion) Forecast, by Application 2020 & 2033
Table 52: Nordics Automated Biobanking Volume (K) Forecast, by Application 2020 & 2033
Table 53: Rest of Europe Automated Biobanking Revenue (billion) Forecast, by Application 2020 & 2033
Table 54: Rest of Europe Automated Biobanking Volume (K) Forecast, by Application 2020 & 2033
Table 55: Global Automated Biobanking Revenue billion Forecast, by Type 2020 & 2033
Table 56: Global Automated Biobanking Volume K Forecast, by Type 2020 & 2033
Table 57: Global Automated Biobanking Revenue billion Forecast, by Application 2020 & 2033
Table 58: Global Automated Biobanking Volume K Forecast, by Application 2020 & 2033
Table 59: Global Automated Biobanking Revenue billion Forecast, by Country 2020 & 2033
Table 60: Global Automated Biobanking Volume K Forecast, by Country 2020 & 2033
Table 61: Turkey Automated Biobanking Revenue (billion) Forecast, by Application 2020 & 2033
Table 62: Turkey Automated Biobanking Volume (K) Forecast, by Application 2020 & 2033
Table 63: Israel Automated Biobanking Revenue (billion) Forecast, by Application 2020 & 2033
Table 64: Israel Automated Biobanking Volume (K) Forecast, by Application 2020 & 2033
Table 65: GCC Automated Biobanking Revenue (billion) Forecast, by Application 2020 & 2033
Table 66: GCC Automated Biobanking Volume (K) Forecast, by Application 2020 & 2033
Table 67: North Africa Automated Biobanking Revenue (billion) Forecast, by Application 2020 & 2033
Table 68: North Africa Automated Biobanking Volume (K) Forecast, by Application 2020 & 2033
Table 69: South Africa Automated Biobanking Revenue (billion) Forecast, by Application 2020 & 2033
Table 70: South Africa Automated Biobanking Volume (K) Forecast, by Application 2020 & 2033
Table 71: Rest of Middle East & Africa Automated Biobanking Revenue (billion) Forecast, by Application 2020 & 2033
Table 72: Rest of Middle East & Africa Automated Biobanking Volume (K) Forecast, by Application 2020 & 2033
Table 73: Global Automated Biobanking Revenue billion Forecast, by Type 2020 & 2033
Table 74: Global Automated Biobanking Volume K Forecast, by Type 2020 & 2033
Table 75: Global Automated Biobanking Revenue billion Forecast, by Application 2020 & 2033
Table 76: Global Automated Biobanking Volume K Forecast, by Application 2020 & 2033
Table 77: Global Automated Biobanking Revenue billion Forecast, by Country 2020 & 2033
Table 78: Global Automated Biobanking Volume K Forecast, by Country 2020 & 2033
Table 79: China Automated Biobanking Revenue (billion) Forecast, by Application 2020 & 2033
Table 80: China Automated Biobanking Volume (K) Forecast, by Application 2020 & 2033
Table 81: India Automated Biobanking Revenue (billion) Forecast, by Application 2020 & 2033
Table 82: India Automated Biobanking Volume (K) Forecast, by Application 2020 & 2033
Table 83: Japan Automated Biobanking Revenue (billion) Forecast, by Application 2020 & 2033
Table 84: Japan Automated Biobanking Volume (K) Forecast, by Application 2020 & 2033
Table 85: South Korea Automated Biobanking Revenue (billion) Forecast, by Application 2020 & 2033
Table 86: South Korea Automated Biobanking Volume (K) Forecast, by Application 2020 & 2033
Table 87: ASEAN Automated Biobanking Revenue (billion) Forecast, by Application 2020 & 2033
Table 88: ASEAN Automated Biobanking Volume (K) Forecast, by Application 2020 & 2033
Table 89: Oceania Automated Biobanking Revenue (billion) Forecast, by Application 2020 & 2033
Table 90: Oceania Automated Biobanking Volume (K) Forecast, by Application 2020 & 2033
Table 91: Rest of Asia Pacific Automated Biobanking Revenue (billion) Forecast, by Application 2020 & 2033
Table 92: Rest of Asia Pacific Automated Biobanking Volume (K) Forecast, by Application 2020 & 2033

Methodology

Step 1 - Identification of Relevant Samples Size from Population Database

Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.

Note*: In applicable scenarios

Step 3 - Data Sources

Primary Research

Web Analytics
Survey Reports
Research Institute
Latest Research Reports
Opinion Leaders

Secondary Research

Annual Reports
White Paper
Latest Press Release
Industry Association
Paid Database
Investor Presentations

Step 4 - Data Triangulation

Involves using different sources of information in order to increase the validity of a study

These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.

Frequently Asked Questions

1. What is the projected Compound Annual Growth Rate (CAGR) of the Automated Biobanking?

The projected CAGR is approximately 9.5%.

2. Which companies are prominent players in the Automated Biobanking?

Key companies in the market include Haier Biomedical, Hamilton, SPT Labtech, Azenta (formerly Brooks Automation), Thermo Fisher Scientific, IRELEC, MGI Tech, Askion Biobanking, Labplan, Liconic, BioLife Solutions.

3. What are the main segments of the Automated Biobanking?

The market segments include Type, Application.

4. Can you provide details about the market size?

The market size is estimated to be USD 2.03 billion as of 2022.

5. What are some drivers contributing to market growth?

N/A

6. What are the notable trends driving market growth?

N/A

7. Are there any restraints impacting market growth?

N/A

8. Can you provide examples of recent developments in the market?

N/A

9. What pricing options are available for accessing the report?

Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4480.00, USD 6720.00, and USD 8960.00 respectively.

10. Is the market size provided in terms of value or volume?

The market size is provided in terms of value, measured in billion and volume, measured in K.

11. Are there any specific market keywords associated with the report?

Yes, the market keyword associated with the report is "Automated Biobanking," which aids in identifying and referencing the specific market segment covered.

12. How do I determine which pricing option suits my needs best?

The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.

13. Are there any additional resources or data provided in the Automated Biobanking report?

While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.

14. How can I stay updated on further developments or reports in the Automated Biobanking?

To stay informed about further developments, trends, and reports in the Automated Biobanking, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.

Get Free Sample

Pre Order Enquiry Request discount

Pricing

Related Reports

Biobank Service Unlocking Growth Potential: Analysis and Forecasts 2025-2033

Biobanking Software Unlocking Growth Potential: Analysis and Forecasts 2025-2033

Biobanking Services Decade Long Trends, Analysis and Forecast 2025-2033

Biobanking Equipment 2025 to Grow at 6.5 CAGR with 1389.2 million Market Size: Analysis and Forecasts 2033

Biobanking Sample Unlocking Growth Potential: Analysis and Forecasts 2025-2033

Tailored for you

In-depth Analysis Tailored to Specified Regions or Segments
Company Profiles Customized to User Preferences
Comprehensive Insights Focused on Specific Segments or Regions
Customized Evaluation of Competitive Landscape to Meet Your Needs
Tailored Customization to Address Other Specific Requirements

Ask for customization

The response was good, and I got what I was looking for as far as the report. Thank you for that.

Erik Perison

US TPS Business Development Manager at Thermon

As requested- presale engagement was good, your perseverance, support and prompt responses were noted. Your follow up with vm’s were much appreciated. Happy with the final report and post sales by your team.

Shankar Godavarti

Global Product, Quality & Strategy Executive- Principal Innovator at Donaldson

I have received the report already. Thanks you for your help.it has been a pleasure working with you. Thank you againg for a good quality report

Jared Wan

Analyst at Providence Strategic Partners at Petaling Jaya

Related Reports

Biobank Service

Biobank Service Unlocking Growth Potential: Analysis and Forecasts 2025-2033

Biobanking Software

Biobanking Software Unlocking Growth Potential: Analysis and Forecasts 2025-2033

Biobanking Services

Biobanking Services Decade Long Trends, Analysis and Forecast 2025-2033

Biobanking Equipment

Biobanking Equipment 2025 to Grow at 6.5 CAGR with 1389.2 million Market Size: Analysis and Forecasts 2033

Biobanking Sample

Biobanking Sample Unlocking Growth Potential: Analysis and Forecasts 2025-2033

About Market Research Forecast

MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.

Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.